2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
7
Brain Neoplasms
4
Pain
2
Neuralgia
2
Glioma
2
Depression
2
Visceral Pain
1
Recurrence
1
Rectal Neoplasms
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Neurologic Manifestations
1
Lymphoma, Follicular
1
Language Disorders
1
Headache
1
Glioblastoma
1
Fatigue
1
Depressive Disorder, Major
1
Cognitive Dysfunction
1
Carcinoma, Renal Cell
1
Cancer Survivor
1
Anxiety Disorders
1
Agnosia
1
Acromegaly
1
Interventions
Escitalopram
3
Psilocybin
2
Interpersonal Psychotherapy
2
Infliximab
2
Antidepressive Agents
2
abacavir
1
Vortioxetine
1
Venlafaxine Hydrochloride
1
Transcranial Magnetic Stimulation
1
Sugars
1
Saline Solution
1
Mirtazapine
1
Magnetic Resonance Spectroscopy
1
Ketamine
1
Fatty Acids, Omega-3
1
Diagnostic Imaging
1
Desvenlafaxine Succinate
1
Cognitive Behavioral Therapy
1
Citalopram
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Depressive Disorder, Major
×
Transcranial Magnetic Stimulation
×
Clear all
NCT01718730
2019-10-22
Cortical Excitability and Inhibition in MDD
Mayo Clinic
Completed
23 enrolled